#China weight loss drug approval

Total 1 articles

China Opens the Floodgates for Weight-Loss Drugs—Who Wins?

China's approval of Pfizer's GLP-1 weight-loss drug unlocks a massive 1.5 billion-person market. We analyze the winners, losers, and investment implications of this regulatory shift.

Mar 6, 2026